PUBLICATIONS · 15459211
Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2004 Oct 1
- First author
- Thigpen JT
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Thigpen JT
- type
- Author
- name
- Brady MF
- type
- Author
- name
- Homesley HD
- type
- Author
- name
- Malfetano J
- type
- Author
- name
- DuBeshter B
- type
- Author
- name
- Burger RA
- type
- Author
- name
- Liao S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Thigpen JT
- type
- Author
- name
- Brady MF
- type
- Author
- name
- Homesley HD
- type
- Author
- name
- Malfetano J
- type
- Author
- name
- DuBeshter B
- type
- Author
- name
- Burger RA
- type
- Author
- name
- Liao S
- type
- Author
- bibliography ids
- nci-bib-64070d8cb5ed702ffb3bc199
- book metadata
- content sha256
- 4c4ad162060d9acefc02789ee11fb02a982023b401d28b22b4d35e4c035c056c
- document type
- citation
- dois
- 10.1200/JCO.2004.02.088
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15459211
- immutable id
- pubmed:15459211@4c4ad162060d9acefc02789ee11fb02a982023b401d28b22b4d35e4c035c056c
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3902-8
- volume
- 22
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15459211
- provenance
- batch id
- 97b9e848a139d5f8d462
- provider
- NCBI PubMed ESummary
- record sha256
- c941cdc95759df102752f91264029f6af827f80b128947e65da846681e25577b
- response sha256
- a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
- retrieved at
- 2026-09-09T23:45:57.930512+00:00
- publication date
- display
- 2004 Oct 1
- precision
- day
- year
- 2004
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
Preserved source evidence · Not medical advice
Triangle